SOLIGENIX, INC.: Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte for the Treatment of Cutaneous T-Cell Lymphoma
FLASH2 Study opens patient enrollment PRINCETON, N.J., Dec. 16, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused ...
Too Old to Operate2d
Approaches for Identifying Uncertain Tumor Locations in Skin Cancer Surgery
The following is a summary of “How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site ...
The Healthy on MSN3d
12 Silent Signs of Skin Cancer You’re Probably Ignoring
Subtle signs of skin cancer you shouldn't ignore When the weather gets warmer and daylight hours longer, people are more ...